Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1984 Dec;18(3):179–184. doi: 10.1007/BF00205509

Effects of isolated tumor lymphocytes alone and with adherent cells

Beverly A Blazar 1,, Naomi Galili 1, Eva Klein 1
PMCID: PMC11039120  PMID: 6568875

Abstract

The effect on the growth of gradient-isolated mouse mammary tumor cells of different populations of lymphoid cells were evaluated in micrototoxicity assays. Variable effects were obtained with tumor-bearer lymph node and spleen cells: in some experiments growth stimulation occurred, whereas in others inhibition was observed. Mixed effector populations gave more regular results: adherent spleen cells added to lymph node or spleen lymphocytes inhibited tumor cell growth in six of nine experiments; inhibition occurred when either of the effector populations in the mixture was derived from the tumor-bearing mouse. Tumor-associated lymphoid cells (TAL) stimulated growth of the tumor cells in five of seven experiments. However, TAL inhibited tumor growth when combined with adherent spleen cells from tumor-bearing animals. In contrast with the peripheral lymphoid cells, admixture of control adherent cells from normal animals with TAL did not inhibit growth. No natural killer effect was seen in these growth inhibition assays. These data indicate that lymphoid populations capable of inhibiting tumor cell growth can be found in tumor-bearing animals, but such combination of active cells are not present at the tumor site.

Keywords: Natural Killer, Mammary Tumor, Adherent Cell, Effector Population, Lymphoid Cell

References

  • 1.Bernstein ID, Zbar B, Rapp HJ. Impaired inflammatory responses in tumor bearing guinea pigs. J Natl Cancer Inst. 1972;49:1641. doi: 10.1093/jnci/49.6.1641. [DOI] [PubMed] [Google Scholar]
  • 2.Boetcher DA, Leonard EJ. Abnormal monocyte chemotactic response in cancer patients. J Natl Cancer Inst. 1974;52:1091. doi: 10.1093/jnci/52.4.1091. [DOI] [PubMed] [Google Scholar]
  • 3.Blazar BA, Heppner GH. In situ lymphoid cells of mouse mammary tumors I Development and evaluation of a method for the separation of lymphoid cells from mouse mammary tumors. J Immunol. 1978;120:1876. [PubMed] [Google Scholar]
  • 4.Blazar BA, Heppner GH. In situ lymphoid cells of mouse mammary tumors II The characterization of lymphoid cells separated from mouse mammary tumors. J Immunol. 1978;120:1881. [PubMed] [Google Scholar]
  • 5.Blazar BA, Miller FR, Heppner GH. In situ lymphoid cells of mouse mammary tumors. III in vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors. J Immunol. 1978;120:1887. [PubMed] [Google Scholar]
  • 6.Blazar BA, Laing CA, Miller FR, Heppner GH. Activity of lymphoid cells separated from mammary tumors in blastogenesis and Winn assays. J Natl Cancer Inst. 1980;65:405. [PubMed] [Google Scholar]
  • 7.Blazar BA, Vanky F, Klein E. Purified mouse mammary tumor and lymphoid cells in immune assays. Cancer Immunol Immunother. 1984;18:174. doi: 10.1007/BF00205508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Evans R. Macrophages in syngeneic animal tumors. Transplantation. 1972;14:468. doi: 10.1097/00007890-197210000-00011. [DOI] [PubMed] [Google Scholar]
  • 9.Evans R. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: Potential mechanisms of action. Int J Cancer. 1984;33:381. doi: 10.1002/ijc.2910330317. [DOI] [PubMed] [Google Scholar]
  • 10.Fauve RM, Hevin B, Jacob H, Guillard JA, Jacob F. Anti-inflammatory effects of murine malignant cells (endotoxin macrophages inflammation cancer trophoblast) Proc Natl. Acad Sci. 1974;71:4052. doi: 10.1073/pnas.71.10.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gerson JM, Varesio L, Herberman RB. Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors. Int J Cancer. 1981;27:243. doi: 10.1002/ijc.2910270218. [DOI] [PubMed] [Google Scholar]
  • 12.Gerson JM, Tagliabue A, Herberman RB. Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice. J Reticuloendothel Soc. 1981;29:15. [PubMed] [Google Scholar]
  • 13.Johnson RJ, Siliciano RF, Shin HS. Suppression of antibody sensitized tumor cells by macrophages: Insufficient supply or activation of macrophates within large tumors. J Immunol. 1979;122:379. [PubMed] [Google Scholar]
  • 14.Loveless SE, Heppner GH. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and non-metastatic tumors. J Immunol. 1983;131:2074. [PubMed] [Google Scholar]
  • 15.Mantovani A, Peri A, Polentaretti N, Bolis G, Manigioci C, Spreafico F. Effects on in vitro tumor growth of macrophages isolated from human ascitic ovarian tumors. Int J Cancer. 1979;23:157. doi: 10.1002/ijc.2910230204. [DOI] [PubMed] [Google Scholar]
  • 16.Meltzer MS, Stevenson MM. Macrophage function in tumor bearing mice: dissociation of phagocytic and chemotactic responsiveness. Cell Immunol. 1978;35:99. doi: 10.1016/0008-8749(78)90130-2. [DOI] [PubMed] [Google Scholar]
  • 17.North RJ, Kirstein DP, Tuttle RL. Subversion of host defense mechanisms by murine tumors. I. A circulatory factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976;143:559. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Prehn RT, Lappe MA. An immunostimulatory theory of tumor development. Transplant Rev. 1971;7:26. doi: 10.1111/j.1600-065x.1971.tb00462.x. [DOI] [PubMed] [Google Scholar]
  • 19.Rios AM, Miller FR, Heppner GH. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties. Cancer Immunol Immumother. 1983;15:83. doi: 10.1007/BF00199696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Russell SW, McIntosh AT. Macrophages isolated from regressing Maloney sarcomas are more cytotoxic than those recovered from progressing sarcomas. Nature. 1977;268:69. doi: 10.1038/268069a0. [DOI] [PubMed] [Google Scholar]
  • 21.Snyderman R, Pike MC, Blaylock BL. Effects on neoplasms of inflammation: depression of macrophage accumulation after tumor implantation. J Immunol. 1976;116:585. [PubMed] [Google Scholar]
  • 22.Takasugi M, Klein E. A microassay for cell mediated immunity. Transplantation. 1970;9:219. doi: 10.1097/00007890-197003000-00005. [DOI] [PubMed] [Google Scholar]
  • 23.Wood GW, Gillespie GY. Studies on the role of macrophages in regulating growth and metastases of murine chemically induced fibrosarcomas. Int J Cancer. 1975;16:1022. doi: 10.1002/ijc.2910160616. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES